| 03.11.2025 10:41 | ROQ, NFM | SMALL-CAP WINNERS & LOSERS: New Frontier Minerals eyes drill approval | Alliance |
| 03.11.2025 07:00 | ROQ | MK Cell Out-License & Lyramid SPA Update | RNS |
| 16.10.2025 21:51 | SVNS, BUCE, CHL | TRADING UPDATES: Gelion plans fund raise alongside testing agreement | Alliance |
| 16.10.2025 07:00 | ROQ | Fundraise & Transaction Update | RNS |
| 01.10.2025 11:01 | ROQ, TPT, UPL | SMALL-CAP WINNERS & LOSERS: Upland buys Vanguard assets; Topps rises | Alliance |
| 30.09.2025 12:08 | ASHI, RNEW, LBOW | EARNINGS: Billington profit dives; Emmerson and Roquefort narrow loss | Alliance |
| 30.09.2025 11:01 | ROQ, BISI, PRE | SMALL-CAP WINNERS & LOSERS: Pensana eyes US; Bisichi swings to loss | Alliance |
| 30.09.2025 07:00 | ROQ | Interim Results to 30 June 2025 | RNS |
| 24.09.2025 07:00 | ROQ | Investor Presentation via Engage Investor | Reach |
| 08.09.2025 11:14 | ROQ | Roquefort shares surge on Coiled USA reverse takeover proposal | Alliance |
| 08.09.2025 07:00 | ROQ | Proposed Acquisition of Clinical Stage Company | RNS |
| 28.08.2025 14:51 | ROQ | Roquefort Therapeutics further extends deadline for Lyramid sale deal | Alliance |
| 28.08.2025 07:00 | ROQ | Lyramid SPA 2nd Extension & Carve Out | RNS |
| 07.07.2025 07:00 | ROQ | Director/PDMR Shareholding | RNS |
| 30.06.2025 07:00 | ROQ | Director/PDMR Shareholding | RNS |
| 27.06.2025 19:37 | AST, FAR, HAMA | TRADING UPDATES: Likewise optimistic; Brave Bison trading improves | Alliance |
| 27.06.2025 07:00 | ROQ | Lyramid SPA Extension | RNS |
| 26.06.2025 13:00 | ROQ | Results of AGM | RNS |
| 19.06.2025 14:09 | TRN, ROQ, OBI | UK shareholder meetings calendar - next 7 days | Alliance |
| 13.06.2025 16:00 | ROQ | Issue of Equity | RNS |
| 02.06.2025 07:00 | ROQ | Notice of Annual General Meeting | RNS |
| 23.05.2025 07:00 | ROQ | Extension of Convertible Loan Notes | RNS |
| 13.05.2025 07:00 | ROQ | Corporate Update | RNS |
| 30.04.2025 07:00 | ROQ | Annual Report & Financial Statements - 31 Dec 2024 | RNS |
| 14.03.2025 07:00 | ROQ | Private Placing and Conversion of CLNs | RNS |
| 10.03.2025 11:38 | ROQ | Roquefort Therapeutics CEO resigns, agrees terms for Oncogeni disposal | Alliance |
| 10.03.2025 10:04 | SHI, CAPD, ROQ | SMALL-CAP WINNERS & LOSERS: Roquefort jumps on Oncogeni deal | Alliance |
| 10.03.2025 07:30 | ROQ | Board Changes | RNS |
| 10.03.2025 07:00 | ROQ | Proposed Sale of Oncogeni Ltd | RNS |
| 04.03.2025 07:00 | ROQ | Update on Sale of Lyramid | RNS |
| 04.02.2025 10:58 | ROQ | Director/PDMR Shareholding | RNS |
| 03.02.2025 07:00 | ROQ | Share Purchase Agreement Signed - Sale of Lyramid | RNS |
| 02.01.2025 14:08 | ROQ | Roquefort Therapeutics proposes USD10 million subsidiary sale | Alliance |
| 02.01.2025 07:00 | ROQ | Proposed Sale of Midkine Portfolio | RNS |
| 04.12.2024 16:00 | ROQ | Director Share Distribution | RNS |
| 07.11.2024 07:00 | ROQ | Conversion of Convertible Loan Notes | RNS |
| 06.11.2024 07:00 | ROQ | STAT-6 siRNA Presentation | Reach |
| 27.09.2024 13:56 | ROQ, KDNC, VAL | EARNINGS: Kendrick Resources loss narrows; Emmerson CFO to depart | Alliance |
| 27.09.2024 07:00 | ROQ | Interim Results to 30 June 2024 | RNS |
| 23.09.2024 17:51 | ROQ | Roquefort Therapeutics says MK cell therapy patent approved in Japan | Alliance |
| 23.09.2024 07:00 | ROQ | Grant of Japan MK Cell Patent | RNS |
| 19.09.2024 07:00 | ROQ | STAT-6 siRNA Demonstrates Efficacy in Immunology | RNS |
| 02.09.2024 07:00 | ROQ | Grant of MK Cell Patent & Licencing Update | RNS |
